( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57



Ibrahim M.E., Fatehalrahman F. Magbool*, Mahjoub. N.M. Ahmed, Dhia Eldin Elhag, Asim Halfawi, Zuheir Osman, Abdrhman Mahmoud Gamil and Mohamed E. Adam


Colon-targeted drug delivery has been the focus of numerous studies in recent years due to its potential to improve treatment of local diseases affecting the colon, while minimizing systemic side effects. Methods. Metronidazole core tablets were formulated using different polymers in different ratios and the core tablets were coated with an enteric polymer. The formulated enteric coated tablets were evaluated for their compatibility between the active ingredient and the excipients. The prepared tablets were evaluated for weight variation, hardness, friability, content uniformity and in vitro drug release. Results. The pre-compression aspect including determination of various flow property, compatibility testing for the active ingredient and the excipients was conducted using Fourier transform infrared spectrophotometer (FT-IR), all the formulations were passed the tests. The tablets were coated by using polymers, in post-compression aspect the coated tablets were subjected to pharmaceutical evaluation using official and non-official experiments. The overall pharmaceutical acceptability were satisfactory for the developed tablets regarding chemical and physical investigations. also drug content was in the range of 98.44 to 99.89 % indicating good content uniformity in the formulations. The tablets were passed all the tests. Among all the formulations F5 formula was found to be optimized and show better targeted site controlled drug delivery as it was retarded the drug release up to 6 hours and showed maximum of 98.32% drug release. The optimum formulation F5 was stable when it was stored at 45 ± 2°C /75% RH for 3 months. The formulation F5 was considered the most suitable formula for targeted the colon. The pharmaceutical evaluations and in vitro results showed that the Metronidazole tablets formulations can be a potential candidate for colon-targeted drug delivery, with better in vitro characteristics and physicochemical properties. As a result, colon-targeted drug delivery of Metronidazole appeared to be a promising alternative to traditional drug administration routes.

Keywords: Metronidazole, Enteric coated tablets, Pre-compression aspect, In vitro drug release, Colon-targeted drug.

[Full Text Article]




    OCTOBER 2020 Issue has been successfully launched on 1 October 2020.

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 September 2020 Issue has been Published, Kindly check it on

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing